CpG oligonucleotides are effective in immunotherapy of a minimal residual tumour disease after surgery or chemotherapy in a murine model of MHC class I deficient, HPV¨16-associated tumours

REINIŠ, M., ŠÍMOVÁ, J., INDROVÁ, M., BIEBLOVÁ, J., JANDLOVÁ, T., BUBENÍK, J. CpG oligonucleotides are effective in immunotherapy of a minimal residual tumour disease after surgery or chemotherapy in a murine model of MHC class I deficient, HPV¨16-associated tumours. In: Abstract Book. Praha: MSD, 2006, s. 336.